GMRE
Global Medical REIT Inc.
REIT - Healthcare Facilities
Market Cap$94M
5Y Perf.-33.3%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
GMRE vs PLYM
Revenue, margins, valuation, and 5-year total return — side by side.
PLYM
Plymouth Industrial REIT, Inc.
REIT - Industrial
Market Cap$979M
5Y Perf.+47.8%
GMRE vs PLYM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | GMRE | PLYM |
|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Industrial |
| Market Cap | $94M | $979M |
| Revenue (TTM) | $148M | $192M |
| Net Income (TTM) | $2M | $93M |
| Gross Margin | 68.8% | 69.7% |
| Operating Margin | 24.9% | 17.3% |
| Forward P/E | 595.7x | 7.1x |
| Total Debt | $654M | $646M |
| Cash & Equiv. | $7M | $18M |
GMRE vs PLYM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
GMRE
PLYM
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Global Medical REIT… (GMRE) | 100 | 66.7 | -33.3% |
| Plymouth Industrial… (PLYM) | 100 | 147.8 | +47.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GMRE vs PLYM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: PLYM leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Global Medical REIT Inc. is the stronger pick specifically for dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
GMRE
Global Medical REIT Inc.
The Real Estate Income Play
GMRE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 308.1% 10Y total return vs PLYM's 68.9%
- 63.5% yield, 5-year raise streak, vs PLYM's 4.4%
Best for: income & stability and long-term compounding
PLYM
Plymouth Industrial REIT, Inc.
The Real Estate Income Play
PLYM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth -0.7%, EPS growth 14.4%, 3Y rev CAGR 12.2%
- Lower volatility, beta 0.20, current ratio 0.42x
- Beta 0.20, yield 4.4%, current ratio 0.42x
Best for: growth exposure and sleep-well-at-night
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | PLYM | -0.7% FFO/revenue growth vs GMRE's -1.8% |
| Value | PLYM | Lower P/E (7.1x vs 595.7x) |
| Quality / Margins | PLYM | 48.5% margin vs GMRE's 1.7% |
| Stability / Safety | PLYM | Beta 0.20 vs GMRE's 0.48, lower leverage |
| Dividends | GMRE | 63.5% yield, 5-year raise streak, vs PLYM's 4.4% |
| Momentum (1Y) | PLYM | +45.5% vs GMRE's +0.1% |
| Efficiency (ROA) | PLYM | 5.9% ROA vs GMRE's 0.2%, ROIC 2.1% vs 2.0% |
GMRE vs PLYM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLPLYMLAGGINGGMRE
GMREGlobal Medical REIT I…
2leads
PLYMPlymouth Industrial R…
3leads
6 Total Categories
CATEGORYLEADERvs GMREMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
GMRE3/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
PLYM7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
PLYM4/6
Risk & VolatilityBeta, volatility, and downside exposure
PLYM2/2
Analyst OutlookRatings, price targets, and dividends
GMRE2/2
Income & Cash Flow (Last 12 Months)
Evenly matched — GMRE and PLYM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PLYM and GMRE operate at a comparable scale, with $192M and $148M in trailing revenue. PLYM is the more profitable business, keeping 48.5% of every revenue dollar as net income compared to GMRE's 1.7%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | GMREGlobal Medical RE… | PLYMPlymouth Industri… |
|---|---|---|
| RevenueTrailing 12 months | $148M | $192M |
| EBITDAEarnings before interest/tax | $95M | $116M |
| Net IncomeAfter-tax profit | $2M | $93M |
| Free Cash FlowCash after capex | $19M | $95M |
| Gross MarginGross profit ÷ Revenue | +68.8% | +69.7% |
| Operating MarginEBIT ÷ Revenue | +24.9% | +17.3% |
| Net MarginNet income ÷ Revenue | +1.7% | +48.5% |
| FCF MarginFCF ÷ Revenue | +12.6% | +49.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.7% | -1.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -166.2% | -2.5% |
Evenly matched — GMRE and PLYM each lead in 3 of 6 comparable metrics.
Valuation Metrics
GMRE leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
At 7.1x trailing earnings, PLYM trades at a 94% valuation discount to GMRE's 115.3x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than PLYM's 13.3x.
| Metric | GMREGlobal Medical RE… | PLYMPlymouth Industri… |
|---|---|---|
| Market CapShares × price | $94M | $979M |
| Enterprise ValueMkt cap + debt − cash | $741M | $1.6B |
| Trailing P/EPrice ÷ TTM EPS | 115.29x | 7.11x |
| Forward P/EPrice ÷ next-FY EPS est. | 595.67x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.35x | 13.32x |
| Price / SalesMarket cap ÷ Revenue | 0.68x | 4.94x |
| Price / BookPrice ÷ Book value/share | 0.17x | 1.69x |
| Price / FCFMarket cap ÷ FCF | — | 10.19x |
GMRE leads this category, winning 3 of 4 comparable metrics.
Profitability & Efficiency
PLYM leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
PLYM delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $0 for GMRE. PLYM carries lower financial leverage with a 1.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to GMRE's 1.18x. On the Piotroski fundamental quality scale (0–9), PLYM scores 7/9 vs GMRE's 4/9, reflecting strong financial health.
| Metric | GMREGlobal Medical RE… | PLYMPlymouth Industri… |
|---|---|---|
| ROE (TTM)Return on equity | +0.5% | +16.8% |
| ROA (TTM)Return on assets | +0.2% | +5.9% |
| ROICReturn on invested capital | +2.0% | +2.1% |
| ROCEReturn on capital employed | +5.3% | +2.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 1.18x | 1.10x |
| Net DebtTotal debt minus cash | $647M | $628M |
| Cash & Equiv.Liquid assets | $7M | $18M |
| Total DebtShort + long-term debt | $654M | $646M |
| Interest CoverageEBIT ÷ Interest expense | 1.14x | 0.97x |
PLYM leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
PLYM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PLYM five years ago would be worth $13,852 today (with dividends reinvested), compared to $7,855 for GMRE. Over the past 12 months, PLYM leads with a +45.5% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors PLYM at 4.8% vs GMRE's 1.8% — a key indicator of consistent wealth creation.
| Metric | GMREGlobal Medical RE… | PLYMPlymouth Industri… |
|---|---|---|
| YTD ReturnYear-to-date | +6.9% | +0.5% |
| 1-Year ReturnPast 12 months | +0.1% | +45.5% |
| 3-Year ReturnCumulative with dividends | +5.6% | +15.1% |
| 5-Year ReturnCumulative with dividends | -21.4% | +38.5% |
| 10-Year ReturnCumulative with dividends | +308.1% | +68.9% |
| CAGR (3Y)Annualised 3-year return | +1.8% | +4.8% |
PLYM leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
PLYM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PLYM is the less volatile stock with a 0.20 beta — it tends to amplify market swings less than GMRE's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PLYM currently trades 96.7% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | GMREGlobal Medical RE… | PLYMPlymouth Industri… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.20x |
| 52-Week HighHighest price in past year | $39.93 | $22.74 |
| 52-Week LowLowest price in past year | $29.05 | $14.05 |
| % of 52W HighCurrent price vs 52-week peak | +89.5% | +96.7% |
| RSI (14)Momentum oscillator 0–100 | 52.7 | 56.8 |
| Avg Volume (50D)Average daily shares traded | 130K | 132K |
PLYM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
GMRE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates GMRE as "Buy" and PLYM as "Hold". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -4.5% for PLYM (target: $21). For income investors, GMRE offers the higher dividend yield at 63.51% vs PLYM's 4.40%.
| Metric | GMREGlobal Medical RE… | PLYMPlymouth Industri… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $40.00 | $21.00 |
| # AnalystsCovering analysts | 22 | 16 |
| Dividend YieldAnnual dividend ÷ price | +63.5% | +4.4% |
| Dividend StreakConsecutive years of raises | 5 | 1 |
| Dividend / ShareAnnual DPS | $22.70 | $0.97 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% |
GMRE leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
PLYM leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). GMRE leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
Best OverallPlymouth Industrial REIT, I… (PLYM)Leads 3 of 6 categories
Loading custom metrics...
GMRE vs PLYM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is GMRE or PLYM a better buy right now?
For growth investors, Plymouth Industrial REIT, Inc.
(PLYM) is the stronger pick with -0. 7% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Plymouth Industrial REIT, Inc. (PLYM) offers the better valuation at 7. 1x trailing P/E, making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GMRE or PLYM?
On trailing P/E, Plymouth Industrial REIT, Inc.
(PLYM) is the cheapest at 7. 1x versus Global Medical REIT Inc. at 115. 3x.
03Which is the better long-term investment — GMRE or PLYM?
Over the past 5 years, Plymouth Industrial REIT, Inc.
(PLYM) delivered a total return of +38. 5%, compared to -21. 4% for Global Medical REIT Inc. (GMRE). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus PLYM's +68. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GMRE or PLYM?
By beta (market sensitivity over 5 years), Plymouth Industrial REIT, Inc.
(PLYM) is the lower-risk stock at 0. 20β versus Global Medical REIT Inc. 's 0. 48β — meaning GMRE is approximately 135% more volatile than PLYM relative to the S&P 500. On balance sheet safety, Plymouth Industrial REIT, Inc. (PLYM) carries a lower debt/equity ratio of 110% versus 118% for Global Medical REIT Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GMRE or PLYM?
By revenue growth (latest reported year), Plymouth Industrial REIT, Inc.
(PLYM) is pulling ahead at -0. 7% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Plymouth Industrial REIT, Inc. grew EPS 1445% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, PLYM leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GMRE or PLYM?
Plymouth Industrial REIT, Inc.
(PLYM) is the more profitable company, earning 70. 2% net margin versus 4. 8% for Global Medical REIT Inc. — meaning it keeps 70. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus 18. 2% for PLYM. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GMRE or PLYM more undervalued right now?
Analyst consensus price targets imply the most upside for GMRE: 11.
9% to $40. 00.
08Which pays a better dividend — GMRE or PLYM?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 4. 4% for Plymouth Industrial REIT, Inc. (PLYM).
09Is GMRE or PLYM better for a retirement portfolio?
For long-horizon retirement investors, Plymouth Industrial REIT, Inc.
(PLYM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 20), 4. 4% yield). Both have compounded well over 10 years (PLYM: +68. 9%, GMRE: +308. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GMRE and PLYM?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GMRE is a small-cap income-oriented stock; PLYM is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(GMRE: 18.7% · PLYM: -1.4%)P/E Ratio<
x
(GMRE: 115.3x · PLYM: 7.1x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.